IRAs are supposed to provide retirement security for the middle class, not tax avoidance for the wealthy
Shares of credit card giant Visa (NYSE: V) had dropped 4.5% as of 10:40 a.m. EDT Wednesday despite the company beating earnings in its fiscal fourth-quarter 2021 earnings report released last night. Heading into Q4, analysts had forecast that Visa would earn $1.54 per share on revenue of $6.5 billion. As it turned out, Visa "beat" on both the top and bottom lines, reporting adjusted profit of $1.62 per share on sales of $6.6 billion --and when calculated according to generally accepted accounting principles (GAAP), profit of $1.65 per share -- but that wasn't good enough for investors.
Cortexyme executives lauded the study that helped narrow the patient pool for its Alzheimer's drug, but CRTX stock hit a record low on Wednesday.
With the world increasingly recognizing the dire need to switch to clean energy, several economies now see electric vehicles (EVs) as a key part of their energy transition plans. You may not want to miss the race, either, so if you're looking to bet on electric vehicles, here are two top stocks you'd want to buy now. Ford (NYSE: F) is in a much stronger position now than it was roughly a year ago thanks to a leadership change.
If you can't beat them, join them.
A clinical trial showed that patients with the greatest reduction in a specific bacterium saw the greatest cognitive benefit from the South San Francisco company's drug, but the trail failed to meet its primary targets.
Shares of Mastercard (NYSE: MA) had fallen more than 6% as of 12:07 p.m. EDT today after the company's rival Visa (NYSE: V) reported earnings yesterday. For the fourth fiscal quarter of the year, Visa reported earnings per share of $1.65 on total revenue of $6.6 billion. Payments volume at Visa grew 17% from the fourth fiscal quarter of 2020, while cross-border payments volume jumped 38% on a year-over-year basis.
Yahoo Finance's Emily McCormick breaks down the numbers to know from Alphabet's Q3 earnings report.
Shares of Cortexyme Inc. tumbled 72.7% in trading on Wednesday, the day after the company said a late-stage clinical trial evaluating its experimental Alzheimer's disease treatment failed to meet the study's endpoints. Cortexyme's stock is down 43.3% this year; the S&P 500 is up 21.8%.
Yahoo Finance's Jared Blikre breaks down Robinhood's Q3 earnings report.
The company is navigating supply chain challenges well with a record third quarter and even better guidance.
Shares of MP Materials (NYSE: MP) plunged more than 13% by 2:45 p.m. EDT on Tuesday. Weighing on the rare earth mining company stock was a bearish report published by Grizzly Research. Grizzly Research took a swipe at MP Materials.
(Reuters) -Phillips 66 said on Wednesday it will buy the remaining units of Phillips 66 Partners it does not already own for $3.4 billion, as the refiner aims to simplify its governance and corporate structure. Phillips 66 Partners was formed by the refiner to own, operate, develop and acquire primarily fee-based crude oil, refined petroleum products and natural gas liquids pipelines, terminals and other midstream assets. "We believe this acquisition will allow both PSX shareholders and PSXP unitholders to participate in the value creation of the combined entities, supported by the strong financial position of Phillips 66," Chief Executive Officer Greg Garland said in a statement.
With sagging sales and lackluster data in a recent trial, what does the future hold for shareholders?
ViacomCBS Inc (NASDAQ: VIAC) is nearing a sale of its historic CBS Studio Center lot in Los Angeles dubbed the “Radford Lot,” the home of popular TV shows, New York Post reports. Final bids are in for the massive collection of soundstages with Hackman Capital Partners as a leading contender. Earlier this year, Hackman scooped up Sony Pictures Entertainment’s 182,000 square-foot animation campus in Culver City for around $160 million. CBS put its 38-acre campus for sale at auction in late August,
Twitter reported third quarter earnings that missed expectations. Mizuho Analyst James Lee joins Yahoo Finance Live to discuss.
These two hot semiconductor stocks have recently pulled back, but which one should investors snap up?
Enphase Energy Inc. stock rallied more than 25% on Wednesday, poised for its highest close since Jan. 7 and its largest one-day percent increase since March 2020. The stock was the best performing in the S&P 500 index on Wednesday. The energy management technology company late Tuesday reported third-quarter earnings well above Wall Street expectations, saying it earned an adjusted 60 cents a share on sales of $352 million in the quarter, compared with forecasts for adjusted earnings of 49 cents
With SunPower shares also languishing this year, today's big event was the perfect incentive for investors to jump into the stock. SunPower shares were up 8.5% at 11:10 a.m. EDT after popping 11.7% in early-morning trading. After market close Tuesday, Enphase Energy released a stunner of a third-quarter earnings report: Its revenue nearly doubled year over year to hit a record quarterly high of $351.5 million, driven by strong demand for microinverters and a 51% jump in its storage systems shipment.
Wall Street knows it. To put that into perspective, the S&P 500's forward earnings multiple stands at 20.4. The average forward price-to-earnings ratio for pharmaceutical stocks in the index is 13.3.
Fiserv Inc.'s stock is currently the biggest laggard in the S&P 500 Wednesday after the financial-technology company discussed the loss of a large processing customer during its earnings call and gave some more muted commentary around the current quarter than some were expecting.